Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline
Go back to Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline| (NASDAQ: MDGL) | Delayed: 512.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $512.88 | 52 Week High | $18.24 | |||
| Open | $512.88 | 52 Week Low | $6.60 | |||
| Day High | $512.88 | P/E | N/A | |||
| Day Low | $512.88 | EPS | $0.00 | |||
| Volume | 13 | |||||
